Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

Blood (2009) 114 (22): 2609.

https://doi.org/10.1182/blood.V114.22.2609.2609

Published: 2009

Journal Articles

High Dose Intensive Chemotherapy, as Is Standard in Childhood Leukemia, Is Feasible and Efficacious in Adult Patients with Acute Lymphoblastic Leukemia (ALL) up to the Age of 40: Results From the Dutch-Belgian HOVON-70 Study.

A. W Rijneveld, B. van der Holt, S. M. G. J. Daenen, B. J. Biemond, A. A van de Loosdrecht, O. de Weerdt, P. Muus, J. Maertens, V. Mattijssen, H. Demuynck, Mcjc Legdeur, P.W. Wijermans, S. Wittebol, F. Spoelstra, A. W. Dekker, G.J. Ossenkoppele, J. J. Cornelissen, R. Willemze

Blood (2009) 114 (22): 323.

https://doi.org/10.1182/blood.V114.22.323.323

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, J. Cornelissen, MD, R. Willemze, MD, G. Socie, MD, H. Greinix, MD, J. Kienast, MD, R. Hamladji, MD, M. Kazmi, MD, P. Jacobs, MD, N. Schmitz, MD

Blood (2007) 110 (11): 619.

https://doi.org/10.1182/blood.V110.11.619.619

Published: 2007

Journal Articles

Potent B Cell Leukemia-Reactive T Cells Present in Naive Donor T Cell Populations Can Be Isolated under GMP Conditions Using a Universal Stimulation and Isolation Procedure.

I. Jedema, J. Olde Wolbers, E. Steeneveld, A.-M. Rasmussen, W.M. Smit, R. Willemze, J.H. Frederik Falkenburg

Blood (2006) 108 (11): 3689.

https://doi.org/10.1182/blood.V108.11.3689.3689

Published: 2006

Journal Articles

Resistance of Quiescent Cells to T Cell Attack Determines Both the Efficacy and Specificity of Adoptive T Cell Therapy.

I. Jedema, C.A.M. van Bergen, M.G.D. Kester, R. Willemze, J.H. Frederik Falkenburg

Blood (2006) 108 (11): 3161.

https://doi.org/10.1182/blood.V108.11.3161.3161

Published: 2006

Journal Articles

First Line Treatment of Aggressive Cutaneous NK/T Cell Lymphomas Based on High Dose Cytarabine and Stem Cell Transplantation Does Not Lead to Durable Remissions.

C.J.M. Halkes, MD, M.H. Vermeer, MD, E.M. Noordijk, MD, R. Willemze, MD, Roelof Willemze, MD

Blood (2006) 108 (11): 4669.

https://doi.org/10.1182/blood.V108.11.4669.4669

Published: 2006

Journal Articles

Allogeneic (Allo-) or Autologous (Auto-) Peripheral Blood Stem Cell Transplantation (SCT) Randomized Versus a Second Intensive Consolidation after a Common Induction and Consolidation Course in Patients with Bad Prognosis Myelodysplastic Syndromes and Acute Myelogenous Leukemia Following MDS of More Than 6 Months Duration: The Final Analysis of a Joint Study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups.

Blood (2005) 106 (11): 794.

https://doi.org/10.1182/blood.V106.11.794.794

Published: 2005

Journal Articles

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

M. Oosterveld, MD, S. Suciu, M.Sc, P. Muus, MD, M. Delforge, MD, A. Belhabri, MD, C. Aul, MD, D. Selleslag, MD, A. Ferrant, MD, J.-P. Marie, MD, S. Amadori, MD, U. Jehn, MD, U. Hess, MD, R. Willemze, MD, E. Hellstrom-Lindberg, MD, M. Vignetti, MD, B. Labar, MD, F. Mandelli, MD, T. De Witte, MD

Blood (2004) 104 (11): 2020.

https://doi.org/10.1182/blood.V104.11.2020.2020

Published: 2004

Journal Articles

Primary Allogeneic T-Cell Responses Against In Vitro Modified Mantle Cell Lymphoma (MCL) Cells: Implications for Adoptive Immunotherapy after HLA-Matched Stem Cell Transplantation (SCT).

M. Hoogendoorn, MD, J. Olde Wolbers, W. M. Smit, MD PhD, I. Jedema, PhD, M. R. Schaafsma, MD PhD, R. M.Y. Barge, MD PhD, R. Willemze, MD PhD, J. H.F. Falkenburg, MD PhD

Blood (2004) 104 (11): 2118.

https://doi.org/10.1182/blood.V104.11.2118.2118

Published: 2004

Journal Articles

Depletion of In-Vivo Activated Regulatory T Cells Followed by Synchronized Specific In-Vitro Activation Allows the Rapid Isolation of Leukemia-Reactive T Cells for Immunotherapy.

I. Jedema, E. Steeneveld, M. Hoogendoorn, R. Willemze, J.H.F. Falkenburg

Blood (2004) 104 (11): 297.

https://doi.org/10.1182/blood.V104.11.297.297

Published: 2004

Journal Articles

Retroviral Interference with Execution Pathways in Target Cells To Unravel Mechanisms of Cytotoxic T Cell-Mediated Cell Death.

J.F. de Vries, MSc, P.A. von dem Borne, MD, PhD, M.H.M. Heemskerk, PhD, R. Willemze, MD, PhD, J.H.F. Falkenburg, MD, PhD, R.M.Y. Barge, MD, PhD

Blood (2004) 104 (11): 1267.

https://doi.org/10.1182/blood.V104.11.1267.1267

Published: 2004

Journal Articles

Up-Front Window Trial of Gemtuzumab Ozogamicin (GO) in Previously Untreated Elderly Patients with AML: An EORTC Leukemia Group Study.

Sergio Amadori, S. Suciu, R. Willemze, F. Mandelli, D. Selleslag, R. Stauder, A. Ho, C. Denzlinger, G. Leone, G. Fillet, P. Muus, F. Beeldens, O. Anak, T. De Witte

Blood (2004) 104 (11): 877.

https://doi.org/10.1182/blood.V104.11.877.877

Published: 2004

Journal Articles

DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection

M. H. J. Vogt, R. A. de Paus, P. J. Voogt, R. Willemze, J. H. F. Falkenburg

Blood (2000) 95 (3): 1100–1105.

https://doi.org/10.1182/blood.V95.3.1100.003k42_1100_1105

Published: 2000

Journal Articles

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

E.F.M. Posthuma, J.H.F. Falkenburg, J.F. Apperley, A. Gratwohl, E. Roosnek, B. Hertenstein, R.F. Schipper, G.M.T. Schreuder, J. D’Amaro, M. Oudshoorn, J.H. v Biezen, J. Hermans, R. Willemze, D. Niederwieser

Blood (1999) 93 (11): 3863–3865.

https://doi.org/10.1182/blood.V93.11.3863

Published: 1999

Journal Articles

VH Gene Analysis of Primary Cutaneous B-Cell Lymphomas: Evidence for Ongoing Somatic Hypermutation and Isotype Switching

W.M. Aarts, R. Willemze, R.J. Bende, C.J.L.M. Meijer, S.T. Pals, C.J.M. van Noesel

Blood (1998) 92 (10): 3857–3864.

https://doi.org/10.1182/blood.V92.10.3857

Published: 1998

Journal Articles

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

R. Willemze, H. Kerl, W. Sterry, E. Berti, L. Cerroni, S. Chimenti, J.L. Diaz-Peréz, M.L. Geerts, M. Goos, R. Knobler, E. Ralfkiaer, M. Santucci, N. Smith, J. Wechsler, W.A. van Vloten, C.J.L.M. Meijer

Blood (1997) 90 (1): 354–371.

https://doi.org/10.1182/blood.V90.1.354

Published: 1997

Journal Articles

Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia

JC Kluin-Nelemans, MG Kester, JJ Melenhorst, JE Landegent, L van de Corput, R Willemze, JH Falkenburg

Blood (1996) 87 (9): 3795–3802.

https://doi.org/10.1182/blood.V87.9.3795.bloodjournal8793795

Published: 1996

Journal Articles

Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8

L Laterveer, IJ Lindley, DP Heemskerk, JA Camps, EK Pauwels, R Willemze, WE Fibbe

Blood (1996) 87 (2): 781–788.

https://doi.org/10.1182/blood.V87.2.781.bloodjournal872781

Published: 1996

Journal Articles

Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice

WE Fibbe, DP Heemskerk, L Laterveer, JF Pruijt, D Foster, K Kaushansky, R Willemze

Blood (1995) 86 (9): 3308–3313.

https://doi.org/10.1182/blood.V86.9.3308.bloodjournal8693308

Published: 1995

Journal Articles

Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity

LM Faber, SA van Luxemburg-Heijs, WF Veenhof, R Willemze, JH Falkenburg

Blood (1995) 86 (7): 2821–2828.

https://doi.org/10.1182/blood.V86.7.2821.2821

Published: 1995

NARROW

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

High Dose Intensive Chemotherapy, as Is Standard in Childhood Leukemia, Is Feasible and Efficacious in Adult Patients with Acute Lymphoblastic Leukemia (ALL) up to the Age of 40: Results From the Dutch-Belgian HOVON-70 Study.

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

Potent B Cell Leukemia-Reactive T Cells Present in Naive Donor T Cell Populations Can Be Isolated under GMP Conditions Using a Universal Stimulation and Isolation Procedure.

Resistance of Quiescent Cells to T Cell Attack Determines Both the Efficacy and Specificity of Adoptive T Cell Therapy.

First Line Treatment of Aggressive Cutaneous NK/T Cell Lymphomas Based on High Dose Cytarabine and Stem Cell Transplantation Does Not Lead to Durable Remissions.

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

Primary Allogeneic T-Cell Responses Against In Vitro Modified Mantle Cell Lymphoma (MCL) Cells: Implications for Adoptive Immunotherapy after HLA-Matched Stem Cell Transplantation (SCT).

Depletion of In-Vivo Activated Regulatory T Cells Followed by Synchronized Specific In-Vitro Activation Allows the Rapid Isolation of Leukemia-Reactive T Cells for Immunotherapy.

Retroviral Interference with Execution Pathways in Target Cells To Unravel Mechanisms of Cytotoxic T Cell-Mediated Cell Death.

Up-Front Window Trial of Gemtuzumab Ozogamicin (GO) in Previously Untreated Elderly Patients with AML: An EORTC Leukemia Group Study.

DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

VH Gene Analysis of Primary Cutaneous B-Cell Lymphomas: Evidence for Ongoing Somatic Hypermutation and Isotype Switching

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia

Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8

Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice

Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only